Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Total 13F shares
-
64,502,523
-
Share change
-
+3,396,566
-
Total reported value
-
$2,241,446,114
-
Put/Call ratio
-
162%
-
Price per share
-
$34.75
-
Number of holders
-
183
-
Value change
-
+$113,121,712
-
Number of buys
-
73
-
Number of sells
-
115
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2020
As of 31 Mar 2020,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,502,523 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, HILLHOUSE CAPITAL ADVISORS, LTD., JANUS HENDERSON GROUP PLC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, and FARALLON CAPITAL MANAGEMENT LLC.
This page lists
183
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.